{
	"symbol": "SZLS",
	"name": "StageZero Life Sciences Ltd.",
	"price": 0.04,
	"priceChange": 0,
	"percentChange": 0,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Medical Diagnostics & Screening",
	"volume": 0,
	"openPrice": null,
	"dayHigh": null,
	"dayLow": null,
	"MarketCap": 4918115,
	"MarketCapAllClasses": 4942122,
	"peRatio": "",
	"prevClose": 0.04,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": 0.315682,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "StageZero Life Sciences Ltd is a Canadian company, focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. Its lead product, ColonSentry is a blood test to determine the patient's current risk of having colorectal cancer.",
	"fulldescription": "StageZero Life Sciences Ltd is a Canadian company, focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. Its lead product, ColonSentry is a blood test to determine the patient's current risk of having colorectal cancer.",
	"website": "https://www.stagezerolifesciences.com",
	"email": "jht@stagezerols.com",
	"phoneNumber": "+1 905 209-2030",
	"fullAddress": "70 East Beaver Creek Road,Unit 30, Richmond Hill, ON, CA",
	"employees": "40",
	"shareOutStanding": 122952872,
	"totalDebtToEquity": "",
	"totalSharesOutStanding": 123553050,
	"sharesESCROW": null,
	"vwap": null,
	"dividendPayDate": null,
	"weeks52high": 0.04,
	"weeks52low": 0.04,
	"alpha": -0.023806,
	"averageVolume10D": 0,
	"averageVolume20D": 0,
	"averageVolume30D": 0,
	"averageVolume50D": 0,
	"priceToBook": -0.63,
	"priceToCashFlow": 172.1,
	"returnOnEquity": "",
	"returnOnAssets": "",
	"day21MovingAvg": 0.04,
	"day50MovingAvg": 0.04,
	"day200MovingAvg": 0.04,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 0.04,
	"qmdescription": "Diagnostics & Screening",
	"__typename": "Company"
}